Biogen (BIIB) PT Raised to Street High $647 at Truist Securities, Noting Potential for Another $227/sh
Tweet Send to a Friend
(Updated - June 14, 2021 8:54 AM EDT)Truist Securities analyst Robyn Karnauskas raised the price target on Biogen (NASDAQ: BIIB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
